BioLargo extends CFO engagement through Jan 2023; grants 300k-share option at $0.24

BIOLARGO, INC.

CFO Charles K. Dargan II engagement extended one year to January 31, 2023.
Sole compensation: option to purchase 300,000 shares (25,000/month) at $0.24 per share.
Option vests monthly beginning March 2022; no cash compensation for the term.
Option granted under 2018 Equity Incentive Plan, expires ten years from grant date.
Either party can terminate the agreement with 30 days' written notice.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.